Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Johnson & Johnson continues pramlintide collaboration

Aug. 23, 1996

Pramlintide shows positive safety/efficacy profile in phase II

Aug. 23, 1996

Humalog launched on U.S. market

Aug. 23, 1996

Hematopoiesis-stimulating compounds from Nycomed Pharma

Aug. 23, 1996

RIIbeta: Potential antiobesity drug target

Aug. 23, 1996

CCK-A agonist from Glaxo Wellcome

Aug. 23, 1996

New hypolipidemic agent from Schering-Plough

Aug. 23, 1996

Metachol distribution agreement

Aug. 23, 1996

Eisai's squalene synthase inhibitor and prodrug

Aug. 23, 1996

Yamanouchi and PT CarbaPharma describe cathepsin L inhibitor

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...